Donor-Specific Mononuclear Cell Transfusion and Methotrexate as Pretransplant Treatment in Dogs Given DLA-Identical Marrow Grafts after Nonmyeloablative Conditioning

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 8, 2006, Pages 885-886

  Jochum, Christoph ^a   Beste, Mechthild ^a   Zellmer, Eustacia ^a   Graves, Scott S ^a   Storb, Rainer ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CYCLOSPORIN; LYMPHOCYTE ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW TRANSPLANTATION; CELL TRANSFER; CONTROLLED STUDY; DOG; DONOR; GRAFT INFECTION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; LETTER; LYMPHOCYTOPENIA; NEUTROPENIA; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PERIPHERAL BLOOD MONONUCLEAR CELL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DOGS; DOSE-RESPONSE RELATIONSHIP, RADIATION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; LEUKOCYTE TRANSFUSION; TIME FACTORS; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 33746035308     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.04.002     Document Type: Letter

References (8)

1. Storb R., Yu C., Wagner J.L., et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89 (1997) 3048-3054
2. Hogan W.J., Little M.-T., Zellmer E., et al. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. Biol Blood Marrow Transplant 9 (2003) 489-495
3. Storb R., Yu C., Barnett T., et al. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood 94 (1999) 1131-1136
4. Storb R., Yu C., Zaucha J.M., et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 94 (1999) 2523-2529
5. Storb R., Deeg H.J., Whitehead J., et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314 (1986) 729-735
6. Storb R., Kolb H.J., Deeg H.J., et al. Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow. Bone Marrow Transplant 1 (1986) 167-177
7. Ratanatharathorn V., Nash R.A., Przepiorka D., et al. Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host-disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 92 (1998) 2303-2314
8. Strauss G., Osen W., and Debatin K.M. Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. Clin Exp Immunol 128 (2002) 255-266